Current topics in pheochromocytoma

Biomedicine and Pharmacotherapy

Volumn 54, Issue SUPPL. 1, 2000, Pages 124s-128s

  Nakao, K ^a   Itoh, H ^a   Takaya, K ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenal glands; Adrenomullin; Catecholamine; Hypertension; MEN; Neuropeptide Y; Oploid peptides; Pheochromocytoma; RET; Sympathetic nervous system; VHL gene

Indexed keywords

CYCLIC AMP; GLUCOCORTICOID; NEUROPEPTIDE Y;

CATECHOLAMINE BLOOD LEVEL; CLINICAL FEATURE; DISEASE PREDISPOSITION; HUMAN; HYPERTENSION; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SHORT SURVEY; STEM CELL; VON HIPPEL LINDAU DISEASE;

EID: 0033917018     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)80028-1     Document Type: Article

References (38)

1. Young JB, Landsberg L. Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. 9th ed. Philadelphia: W.B. Saunders; 1998. p. 665-728.
2. Unsicker K. The chromaffin cell: paradigm in cell, developmental and growth factor biology. J Anat 1933 ; 183 : 207-21.
3. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994 ; 369 : 658-61.
4. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994 ; 77 : 503-12.
5. Crowly C, Spencer SD, Nishimura MC, Chen KS, PittsMeek S, Armanini MP, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994 ; 76 : 1001-11.
6. Anderson DJ, Carnahan JF, Michelsohn A, Paerson PH. Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage. J Neurosci 1991 ; 11 : 3507-19.
7. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hirai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 1998 ; 3 : 571-8.
8. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985 ; 42 : 581-8.
9. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 ; 363 : 458-60.
10. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993 ; 2 : 851-6.
11. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994 ; 367 : 375-6.
12. Takaya K, Yoshimasa T, Arai H, Tamura N, Miyamoto Y, Itoh H, et al. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin. J Mol Med 1996 ; 74 : 617-21.
13. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996 ; 382 : 70-3.
14. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nercous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994 ; 367 : 380-3.
15. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994 ; 367 : 377-8.
16. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994 ; 54 : 2852-5.
17. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994 ; 3 : 1303-8.
18. Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garrett KP, et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995 ; 269 : 1402-6.
19. Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 1967 ; 215 : 58-9.
20. Yoshimasa T, Nakao K, Ohtsuki H, Li S, Imura H. Methionine-enkephalin and leucine-enkephalin in human sympathoadrenal system and pheochromocytoma. J Clin Invest 1982 ; 69 : 643-50.
21. Hassoun J, Monges G, Giraud P, Henry JF, Charpin C, Payan H, et al. Immunohistochemical study of pheochromocytomas: an investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, β-endorphin, and calcitonin in 16 tumors. Am J Pathol 1984 ; 114 : 56-63.
22. Yoshimasa T, Nakao K, Oki S, Tanaka I, Nakai Y, Imura H. Presence of dynorphin-like immunoreactivity in pheochromocytomas. J Clin Endocr Metab 1981 ; 53 : 213-5.
23. des Senanayake P, Denker J, Bravo EL, Graham RM. Production, characterization, and expression of neuropeptide Y by human pheochromocytoma. J Clin Invest 1995 ; 96 : 2503-9.
24. Boccara G, Mann C, Guillon G. Secretion of vasopressin from a human pheochromocytoma. Ann Intern Med 1998 ; 128 : 1049.
25. Watanabe K, Hiraki H, Hasegawa H, Tanigawa T, Emura I, Honma K, et al. Immunohistochemical localization of endothelin-1, endothelin-3 and endothelin receptors in human pheochromocytoma and paraganglioma. Pathol Int 1997 ; 47 : 540-6.
26. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, et al. Novel autocrine feedback control of catecholamine release - a discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 1997 ; 100 : 1623-33.
27. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993 ; 192 : 553-60.
28. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720-5.
29. Kuwasako K, Kitamura K, Ichiki Y, Kato J, Kangawa K, Matsuo H, et al. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Biochem Biophys Res Commun 1995 ; 211 : 694-9.
30. 2+-dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett 1994 ; 348 : 61-4.
31. 2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC12 cells. J Clin Invest 1996 ; 98 : 14-7.
32. Nakao K, Itoh H, Saito Y, Mukoyama M, Ogawa Y. The natriuretic peptide family. Curr Opin Nephrol Hypertens 1996 ; 5 : 4-11.
33. Suga S, Nakao K, Itoh H, Komatsu Y, OgawaY, Hama N, et al. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor ß? Possible existence of 'vascular natriuretic peptide system'. J Clin Invest 1992 ; 90 : 1145-9.
34. Imura H, Nakao K, Itoh H. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol 1992 ; 13 : 217-49.
35. Mukoyama M, Nakao K, Morii N, Shiono S, Itoh H, Sugawara A, et al. Atrial natriuretic polypeptide (ANP) in bovine adrenal medulla. Hypertension 1988 ; 11 : 692-6.
36. Takeda R. Phaeochromocytoma in Japan: analysis of 493 cases during 1973-1982. J Hypertens 1986 ; 4 : s397-s9.
37. van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, vas der Mey AG, et al. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographies 1991 ; 11 : 37-57.
38. Itoh H, Sugie K, Toyooka S, Kawase M, Mukaino S, Hazama F, et al. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome. Eur J Nucl Med 1986 ; 11 : 502-4.